Company : Abbott Pharmaceuticals
Brand Analysis Count : 422
Pediasure is a leading global brand in the pediatric nutrition segment.The brand is owned by the pharmaceutical giant Abbott. Pediasure was launched in India way back in 2000. But it is only recently that I noticed an ad for this global brand.
Pediasure is a food supplement for children aged 2-10. The brand is fighting for its share in the Rs 0.56 billion pediatric nutrition market in India. But compared to other competitors, the brand was virtually silent in the Indian market.
There is a reason behind this very soft marketing by the brand. Pediasure is basically a therapeutic supplement.According to the brand site, Pediasure is a food supplement for those kids who are picky eaters and those kids who are suffering from some diseases. This is a highly recommended supplement for those kids who are malnourished because they refuse to eat. So most of the sales would have happened through suggestions/prescriptions from doctors and also through word of mouth. A google search indicates that the brand has lot of equity among the consumers.
But by limiting its promotion, the brand had severely undermined its potential to become a popular choice among mothers. The brand has been perceived as a solution for those kids who have chronic problems thus alienating other consumers who are in need of a nutritional supplement.
The brand may have realized the potential now and have started advertising. The ad is projecting Pediasure as a supplement for all those kids who does not like taking food.The current strategy for the brand is to appeal to a larger section of mothers who feel that their child is not getting enough nutrition.
What will be a problem for Pediasure is its price. The brand is priced at around Rs 399 for 400 gm which is almost double the price of brands like Horlicks and Boost. Infact I did not buy this product for my kid ( not malnourished !!!) because of the price. The price is going to make this brand unaffordable for many middle-class customers. The brand could do well if it launches smaller SKUs of 100gms at a reasonable price point .
But for a parent whose child is severely malnutritioned , this price will not be a major issue because of necessity. I recently talked to my newspaper agent whose child was prescribed Pediasure by the doctor . The poor guy was lamenting about the high price of this product. For such consumers, smaller SKUs will make life little more easier.
The price problem becomes a sumbling block when the brand tries to get into the larger market of ordinary consumers. The brand's strategy as of now may be to explore the premium segment of the market.